Ultragenyx: A Promising Bet On Rare Genetic Disorder Therapies Seeking Alpha, 29 May 2023 Summary Ultragenyx's pipeline boasts a diverse array of gene therapy candidates, including UX111, DTX401, DTX301, and UX701…